Загрузка...
Emerging Data with Antiangiogenic Therapies in Early and Advanced Non–Small-Cell Lung Cancer
Lung cancer is the leading cause of cancer-related mortality in the United States. Patients treated with adjuvant chemotherapy have a 5-year survival rate of 25% to 70% depending on stage, whereas those with advanced disease have a median survival of approximately 8 months when treated with standard...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3528174/ https://ncbi.nlm.nih.gov/pubmed/19362948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CLC.2009.s.002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|